HIV and HCV: Distinct infections with important overlapping challenges

Journal of the International AIDS Society

Volumn 17, Issue , 2014, Pages

  Wiktor, Stefan ^a   Ford, Nathan ^a   Ball, Andrew ^a   Hirnschall, Gottfried ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FINANCIAL MANAGEMENT; HEALTH CARE ACCESS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; PATIENT CARE; PRIORITY JOURNAL; SCALE UP; SOCIETY; COINFECTION; COMPLICATION; HEALTH CARE DELIVERY; HEPATITIS C, CHRONIC; HIV INFECTIONS; PROCEDURES;

COINFECTION; COMMUNICABLE DISEASE CONTROL; HEALTH SERVICES ACCESSIBILITY; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS;

EID: 84907417367     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.17.1.19323     Document Type: Article

References (11)

1. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44 1 Suppl:S6-9. (Pubitemid 43053865)
2. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32(3):492-7. (Pubitemid 32173638)
3. Ezzell C. AZT given the green light for clinical treatment of AIDS. Nature. 1987;326(6112):430.
4. Sidwell RW, Huffman JH, Khare GP, Allen LB, Witkowski JT, Robins RK. Broadspectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4- triazole-3-carboxamide. Science. 1972;177(4050):705-6.
5. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Soc. 1957;147(927):258-67.
6. Clayden P, Collins S, Daniels C, Frick M, Harrington M, Horn T, et al. Hepatitis C drug development catapults on. 2013 Pipeline Report. New York: Treatment Action Group; 2014.
7. Sabapathy K, Van den Bergh R, Fidler S, Hayes R, Ford N. Uptake of homebased voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med. 2012;9(12):1001351.
8. Anon. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. Geneva: WHO; 2013.
9. Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006;368(9534):505-10. (Pubitemid 44142772)
10. Arora S, Thornton K, Murata G, Deming P, Kalishman S, Dion D, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med. 2011;364(23):2199-207.
11. Hill WD, Butt G, Alvarez M, Krajden M. Capacity enhancement of hepatitis C virus treatment through integrated, community-based care. Can J Gastroenterol. 2008;22(1):27-32. (Pubitemid 351385648)